Cysteine proteinase inhibitor cystatin A in breast cancer

Cancer Research

Volumn 58, Issue 3, 1998, Pages 432-436

  Kuopio, Teijo ^a   Kankaanranta, Ari ^a   Jalava, Päivi ^a   Kronqvist, Pauliina ^a   Kotkansalo, Tero ^a   Weber, Ekkehard ^b   Collan, Yrjö ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN; CYSTEINE PROTEINASE INHIBITOR; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MITOSIS; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TISSUE SECTION; TUMOR VOLUME;

EID: 0032005987     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Rinne, A. Cystatin A. In: A. Haeberli (ed.), Human Protein Data. Weinheim, Germany: VCH Verlagsges. mbH, 1995.
2. Kirschke, H., Barrett, A. J., and Rawlings, N. D. Lysosomal cysteine proteinases. Protein Profile, 2: 1587-1643, 1995.
3. Rinne, A., Järvinen, M., and Räsänen, O. A protein reminiscent of the epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat. Acta Histochem., 63: 183-192, 1978.
4. Rinne, A., Alavaikko, M., Järvinen, M., Martikainen, J., Karttunen, T., and Hopsu-Havu, V. K. Demonstration of immunoreactive acid cysteine-proteinase inhibitor in reticulum cells of lymph node germinal centres. Virchows Arch. B Cell Pathol., 43: 121-126, 1983.
5. Söderström, K. O., Rinne, R., Hopsu-Havu, V. K., Järvinen, M., and Rinne, A. Identification of acid cysteine proteinase inhibitor (cystatin A) in the human thymus. Anat. Rec., 240: 115-119, 1994.
6. Green, G. D., Kembhavi, A. A., Davies, M. E., and Barrett, A. J. Cystatin-like cysteine proteinase inhibitors from human liver. Biochem. J., 218: 939-946, 1984.
7. Davies, M. E., and Barrett, A. J. Immunolocalization of human cystatins in neutrophils and lymphocytes. Histochemistry, 80: 373-377, 1984.
8. Söderström, K. O., Laato, M., Wu, P., Hopsu-Havu, V. K., Nurmi, M., and Rinne, A. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma. Int. J Cancer, 62: 1-4, 1995.
9. Calkins, C. C., and Sloane, B. F. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol. Chem. Hoppe-Seyler, 376: 71-80, 1995.
10. Hawley-Nelson, P., Roop, D., Cheng, C., Krieg, T., and Yuspa, S. Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Mol. Carcinog., 1: 202-211, 1988.
11. Rinne, A. Epidermal SH-protease inhibitor in human neoplasms and their metastases. Pathol. Res. Pract., 170: 171-179, 1980.
12. Lah, T. T., Kokalj-Kunovar, M., Drobnic-Kosorok, M., Babnik, J., Golouh, R., Vrhovec, I., and Turk, V. Cystatins and cathepsins in breast carcinoma. Biol. Chem. Hoppe-Seyler, 373: 595-604, 1992.
13. Lah, T., Kos, J., Blejec, A., Frkovic-Georgio, S., Golouh, R., Vrhovec, I., and Turk, V. The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol. Oncol. Res., 3: 89-99, 1997.
14. Rinne, A., Järvinen, M., Räsänen, O., and Hopsu-Havu, V. K. Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and infiltrative carcinoma of the uterine portio. Exp. Pathol. (Jena), 26: 67-70, 1984.
15. Eide, T. J., Järvinen, M., Hopsu-Havu, V. K., Maltau, J., and Rinne, A. Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix. Acta Histochem., 93: 241-248, 1992.
16. Lah, T. T., Clifford, J. L., Helmer, K. M., Day, N. A., Moin, K., Honn, K. V., Crissman, J. D., and Sloane, B. F. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim. Biophys. Acta, 993: 63-73, 1989.
17. Alavaikko, M., Aine, R., Rinne, A., Järvinen, M., Blanco, G., Apaja-Sarkkinen, M., and Hopsu-Havu, V. K. Behaviour of dendritic reticulum cells possessing immunoreactive acid cysteine-proteinase inhibitor in human lymphoid secondary follicles and in follicular-centre cell lymphomas. Int. J. Cancer, 35: 319-325, 1985.
18. Söderström, K. O., Rinne, R., Hopsu Havu, V. K., Järvinen, M., and Rinne, A. Hodgkin's disease: a malignancy of follicular dendritic cells? Lancet, 343: 422-423, 1994.
19. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75: 641-652, 1993.
20. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirements of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond.), 375: 81-83, 1995.
21. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
22. Patel, T., Gores, G. J., and Kaufmann, S. H. The role of proteases during apoptosis. FASEB J., 10: 587-597, 1996.
23. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380: 723-726, 1996.
24. Bump, N. J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., Li, P., Licari, P., Mancovich, J., Shi, L., Greenberg, A. H., Miller, L. K., and Wong, W. W. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (Washington DC), 269: 1885-1888, 1995.
25. Chow, S. C., Weis, M., Kass, G. E., Holmstrom, T. H., Eriksson, J. E., and Orrenius, S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett., 364: 134-138, 1995.
26. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
27. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A., and Yuan, J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75: 653-660, 1993.
28. Takahashi, A., Goldschmidt-Clermont, P. J., Alnemri, E. S., Fernandes-Alnemri, T., Yoshizawa-Kumagaya, K., Nakajima, K., Sasada, M., Poirier, G. G., and Earnshaw, W. C. Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. Exp. Cell Res., 231: 123-131, 1997.
29. Mirzoeva, O. K., Yaqoob, P., Knox, K. A., and Calder, P. C. Inhibition of ICE-family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis. FEBS Lett., 396: 266-270, 1996.
30. Guenette, R., Mooibroek, M., Wong, K., Wong, P., and Tenniswood, M. Cathepsin B, a cysteine protease implicated in metastatic progression, is expressed during regression of the rat prostate and mammary glands. Eur. J. Biochem., 226, 311-321, 1994.
31. Björklund, H. V., Johansson, T. R., and Rinne, A. Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. J. Virol., 71: 5658-5662, 1997.
32. Lipponen, P. K., and Collan, Y. Simple quantitation of immunohistochemical staining positivity in microscopy for histopathology routine. Acta Stereol., 11: 125-132, 1992.
33. Haapasalo, H., Pesonen, E., and Collan, Y. Volume corrected mitotic index (M/V index). The standard of mitotic activity in neoplasms. Pathol. Res. Pract., 185: 551-554, 1989.
34. Collan, Y. U., Kuopio, T., Baak, J. P., Becker, R., Bogomoletz, W. V., Deverell, M., van Diest, P., van Galen, C., Gilchrist, K., Javed, A., Kosma, V. M., Kujari, H., Luzi, P., Mariuzzi, G. M., Matze, E., Montironi, R., Scarpelli, M., Sierra, D., Sisti, S., Toikkanen, S., Tosi, P., Whimster, W. F., and Wisse, E. Standardized mitotic counts in breast cancer. Evaluation of the method. Pathol. Res. Pract., 192: 931-941, 1996.
35. Collet, D. Modelling Survival Data in Medical Research. London. Glasgow, New York, Tokyo, Melbourne, Madras: Chapman & Hall, 1994.
36. Lah, T. T., Kokalj-Kunovar, M., Strukelj, B., Pungercar, L. Barlic-Maganja, D., Drobnic-Kosorok, M., Kastelic, L., Babnik, J., Golouh, R., and Turk, V. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int. J. Cancer, 50: 36-44, 1992.
37. Farber, E., and Sarma, D. Hepatocarcinogenesis. A dynamic cellular perspective. Lab. Invest., 56: 4-22, 1987.
38. Joensuu, H., Pylkkänen, L., and Toikkanen, S. Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol., 145: 1191-1198, 1994.
39. Lipponen, P., Pietiläinen, T., Kosma, V. M., Aaltomaa, S., Eskelinen, M., and Syrjänen, K. Apoptosis-suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol., 177: 49-55, 1995.
40. Lee, W. Y., Jin, Y. T., and Tzeng, C. C. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma. Anticancer Res., 16: 3007-3012, 1996.